By the Numbers: Cataracts, Refractive Surgery & Glaucoma CAP Assessment
Final results are now available for the summer CAP assessment. ABO Diplomates who took the assessment may be curious about their performance in comparison to their colleagues. Others may be interested in survey responses showing the impact of the readings and preparation for the assessment
Please note that we’re unable to provide direct answers to specific questions as some Diplomates will be retaking the assessment in their 4th year.
If there is specific information that you’d like to see in future CAP summaries that we haven’t provided here, please let us know.
Cataracts, Refractive Surgery and Glaucoma CAP Assessment
Dates available: May 15, 2024 through August 31, 2024
Overall Performance
Pass/fail cut point: 80% (20/25 questions)
Passing rate: 99.5%
Average score: 93.2% (23.3/25 questions correct)
Performance by Question
Myopic refractive surgery article (Questions 1-4): Average percentage correct: 98.5%
6-year LiGHT trial article (Questions 5-8): Average percentage correct: 97.0%
Glaucoma medications and OSD article (Questions 9-12): Average percentage correct: 92.0%
Fundamental knowledge (Questions 13-25): Average percentage correct: 90.8%
Easiest question: 10 questions scored 99% correct
Most difficult question (62% correct): Question 24 (fundamental knowledge question about toxic anterior segment syndrome). Note: This question had the highest point biserial value on the assessment, indicating that it discriminated well.
Survey Responses
How will your practice behavior change as a result of the “Outcomes of Myopic Refractive Surgery” article? (Select all that apply)
11.2% | I do not anticipate implementing any changes. |
43.8% | My current practice will not change, but it has been reinforced by the information in this article. |
1.7% | I need more information before making changes to my practice. |
45.3% | I will be better prepared to educate my potential refractive surgery patients. |
4.2% | I will be more likely to refer my myopic patients for refractive surgery. |
0.5% | I will be less likely to refer my myopic patients for refractive surgery |
How will your practice behavior change as a result of the “LiGHT Trials” article? (Select all that apply)
5.3% | I do not anticipate implementing any changes. |
29.5% | My current practice will not change, but it has been reinforced by the information in this article. |
2.9% | I need more information before making changes to my practice. |
56.3% | I am more likely to recommend SLT to my newly-diagnosed glaucoma patients. |
24.4% | I am better prepared to educate my glaucoma patients about SLT. |
How will your practice behavior change as a result of the “Glaucoma Medications and OSD” article? (Select all that apply)
5.5% | I do not anticipate implementing any changes |
27.5% | My current practice will not change, but it has been reinforced by the information in this article. |
1.5% | I need more information before making changes to my practice. |
47.1% | I am more likely to recommend SLT to my glaucoma patients with OSD. |
28.9% | I am more confident in my ability to appropriately manage glaucoma patients with OSD. |
23.1% | I am more likely to prescribe preservative-free IOP-lowering eye drops to my glaucoma patients. |
Which of the following best describes your experience with the fundamental knowledge (FK) section of this assessment?
31.7% | I’m confident in my knowledge of these topics and the FK section did nothing to change that. |
24.6% | I was confident in my knowledge of these topics, but now realize that I need to improve/update my knowledge. |
43.1% | I’m now more confident in my overall knowledge of these topics. |
0.6% | I’m not very confident in my knowledge of these topics and the FK section did nothing to change that. |
I'M A DIPLOMATE/CANDIDATE
LEARNING BUILDER ACCOUNT ACCESS
Check Board Certification Status
By going through the voluntary process of becoming board certified, our Diplomates demonstrate competence beyond entry level.
Upcoming Events
Stay in the know about exams, training, and more by visiting our events page.